Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Allman

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Immunity|October 8, 1999
Notch1 expression in early lymphopoiesis influences B versus T lineage determinationJ C Pui, D Allman, L Xu, et al.
The Annals of Thoracic Surgery|April 17, 2022
Multimodal Pain Management Protocol to Decrease Opioid Use and to Improve Pain Control After Thoracic SurgeryIsabel C Clark, Robert D Allman, Austin L Rogers, et al.
Immunity|April 6, 2001
Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strengthD J Izon, J A Punt, L Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2017
A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients With Metastatic Renal Cell CarcinomaMoshe C Ornstein, Laura S Wood, Paul Elson, et al.
Journal for Immunotherapy of Cancer|October 19, 2018
Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumabHaris Zahoor, Pedro C Barata, Xuefei Jia, et al.
Clinical Genitourinary Cancer|March 3, 2019
Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint InhibitorsMoshe C Ornstein, Cassandra Calabrese, Laura S Wood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II studyE Van Cutsem, M Findlay, B Osterwalder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2020
Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint InhibitorsAnita Gul, Tyler F Stewart, Charlene M Mantia, et al.
The Lancet. Oncology|August 21, 2019
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 studyMoshe C Ornstein, Sumanta K Pal, Laura S Wood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2001
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III studyE Van Cutsem, C Twelves, J Cassidy, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Immunity|October 8, 1999
Notch1 expression in early lymphopoiesis influences B versus T lineage determinationJ C Pui, D Allman, L Xu, et al.
The Annals of Thoracic Surgery|April 17, 2022
Multimodal Pain Management Protocol to Decrease Opioid Use and to Improve Pain Control After Thoracic SurgeryIsabel C Clark, Robert D Allman, Austin L Rogers, et al.
Immunity|April 6, 2001
Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strengthD J Izon, J A Punt, L Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2017
A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients With Metastatic Renal Cell CarcinomaMoshe C Ornstein, Laura S Wood, Paul Elson, et al.
Journal for Immunotherapy of Cancer|October 19, 2018
Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumabHaris Zahoor, Pedro C Barata, Xuefei Jia, et al.
Clinical Genitourinary Cancer|March 3, 2019
Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint InhibitorsMoshe C Ornstein, Cassandra Calabrese, Laura S Wood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II studyE Van Cutsem, M Findlay, B Osterwalder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2020
Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint InhibitorsAnita Gul, Tyler F Stewart, Charlene M Mantia, et al.
The Lancet. Oncology|August 21, 2019
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 studyMoshe C Ornstein, Sumanta K Pal, Laura S Wood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2001
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III studyE Van Cutsem, C Twelves, J Cassidy, et al.
Pageof 5